Table 4 Trends of antihypertensive medication use,2002–2021
Year | Treated total | Monotherapy | Dual therapy | 3 classes or more | |||
|---|---|---|---|---|---|---|---|
Number (×1,000) | Number (×1,000) | Percent | Number (×1,000) | Percent | Number (×1,000) | Percent | |
2002 | 2,523 | 1,434 | 56.9 | 785 | 31.1 | 303 | 12.0 |
2003 | 3,213 | 1,669 | 52.0 | 1,088 | 33.9 | 456 | 14.2 |
2004 | 3,720 | 1,794 | 48.2 | 1,321 | 35.5 | 606 | 16.3 |
2005 | 4,468 | 2,045 | 45.8 | 1,624 | 36.3 | 799 | 17.9 |
2006 | 4,993 | 2,201 | 44.1 | 1,831 | 36.7 | 961 | 19.2 |
2007 | 5,398 | 2,338 | 43.3 | 1,973 | 36.6 | 1,087 | 20.1 |
2008 | 5,770 | 2,454 | 42.5 | 2,121 | 36.8 | 1,194 | 20.7 |
2009 | 6,182 | 2,536 | 41.0 | 2,352 | 38.0 | 1,294 | 20.9 |
2010 | 6,538 | 2,578 | 39.4 | 2,555 | 39.1 | 1,405 | 21.5 |
2011 | 6,772 | 2,627 | 38.8 | 2,721 | 40.2 | 1,424 | 21.0 |
2012 | 7,220 | 2,815 | 39.0 | 2,931 | 40.6 | 1,474 | 20.4 |
2013 | 7,499 | 2,965 | 39.5 | 3,078 | 41.0 | 1,456 | 19.4 |
2014 | 7,696 | 3,111 | 40.4 | 3,211 | 41.7 | 1,374 | 17.9 |
2015 | 7,944 | 3,251 | 40.9 | 3,334 | 42.0 | 1,359 | 17.1 |
2016 | 8,297 | 3,409 | 41.1 | 3,516 | 42.4 | 1,372 | 16.5 |
2017 | 8,633 | 3,534 | 40.9 | 3,710 | 43.0 | 1,389 | 16.1 |
2018 | 9,027 | 3,672 | 40.7 | 3,905 | 43.3 | 1,450 | 16.1 |
2019 | 9,512 | 3,865 | 40.6 | 4,127 | 43.4 | 1,520 | 16.0 |
2020 | 9,914 | 3,975 | 40.1 | 4,327 | 43.6 | 1,612 | 16.3 |
2021 | 10,455 | 4,161 | 39.8 | 4,579 | 43.8 | 1,714 | 16.4 |